<DOC>
	<DOCNO>NCT02665325</DOCNO>
	<brief_summary>Thyroid carcinoma common endocrine system malignant neoplasm . At present become malignant neoplasm fast grow incidence rate . More 90 % thyroid carcinoma thyroid differentiate carcinoma（DTC） . Postoperative oral L-thyroxine suppressing thyroid stimulate hormone ( TSH ) treatment standard therapy DTC patient . While TSH-suppressive therapy L-thyroxine cause subclinical hyperthyroidism treatment patient thyroid differentiate carcinoma . The impact therapy cognitive function mood systematically study . The investigator infer subclinical hyperthyroidism cause TSH-suppressive therapy may impact cognitive function mood disorder DTC patient . The aim study explore possible mechanism cognitive function impairment course TSH-suppressive therapy rat model total thyroidectomy + TSH-suppressive therapy clinical trial . The result study may provide clinical experimental basis side effect risk result form TSH-suppressive therapy DTC patient .</brief_summary>
	<brief_title>Cognitive Functions During Thyrotropin Suppressive Therapy Patients With Differentiated Thyroid Carcinoma</brief_title>
	<detailed_description>1 . Object : Patients age 18-65 year ; newly diagnose differentiate thyroid carcinoma undergone thyroidectomy accord China thyroid association guideline Management thyroid nodule thyroid cancer ; follow TSH-suppressive therapy 6 /12 month . 2 . Clinical information , examination data neuropsychological assessment : Information obtain medical record abstraction . Serum T3 , T4 , FT3 , FT4 , TSH , TG-ab , TPO-ab , TG level neuropsychological assessment examine TSH-suppressive therapy 6 /12 month . Cognitive complaint assess Mini-Mental State Examination ( MMSE ) , Clock Drawing Test ( CDT ) , Digit Symbol test ( DST ) , Wechsler Memory Scale ( WMS ) , Aphasia Battery Chinese （ABC） patient health questionnaire-9 ( PHQ-9 ) . Healthy volunteer ( normal T3 , T4 , FT3 , FT4 , TSH , TG-ab , TPO-ab , TG ) recruit match patient age , gender , education level , etc .</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<mesh_term>Calcitonin</mesh_term>
	<criteria>Newly diagnose differentiate thyroid carcinoma . Undergo thyroidectomy accord China thyroid association guideline Management thyroid nodule thyroid cancer . Followed TSHsuppressive therapy 6 /12 month . Current past disorder/disease central nervous system medical condition impact cognitive functioning . Head trauma history prolonged loss consciousness . Epilepsy , dementia , learn disability . Current past psychoticspectrum disorder current major affective disorder . Current substance abuse/dependence . Daily tobacco alcohol use . Whole brain irradiation surgery . Prior cancer diagnosis chemotherapy treatment . Active autoimmune disorder . Insulindependent diabetes . Uncontrolled allergic condition asthma . Chronic use oral steroid medication . Hormone therapy ( estrogen , progestin compound ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>TSH-suppressive therapy</keyword>
	<keyword>cognitive function</keyword>
</DOC>